March 16, 2026

Are Oncologists Using Mental Health Services?

Findings suggest opportunities to expand integration mental health services into cancer care.

Conexiant

March 16, 2026

Beyond Morphology and IHC

Can molecular profiling and AI help uncover tumor origin and actionable biomarkers?

The Pathologist

March 12, 2026

ACP Calls for Sweeping Policy Shifts on Disability in Medicine

Twin policy statements in Annals of Internal Medicine outline structural reforms aimed at improving health care access for patients with disabilities and supporting physicians with disabilities in training and practice.

Conexiant

March 10, 2026

Color Vision Tied to Bladder Survival

Patients with impaired color perception may be less likely to recognize blood in urine, potentially delaying diagnosis of cancers that rely on visible bleeding as an early warning sign.

Conexiant

March 06, 2026

Are AI Models Cheating in Biomarker Predictions?

Study finds image-based predictions often reflect confounding factors rather than true molecular signals

The Pathologist

March 05, 2026

What Prevents Chemo-Linked HFS?

Network meta-analysis compares preventive agents for chemotherapy-induced hand-foot syndrome

Conexiant

March 05, 2026

Calcium Strategy Following Thyroidectomy

Investigators compare routine prophylaxis vs postoperative parathyroid hormone-guided supplementation.

Conexiant

March 05, 2026

Why One Number Isn’t Enough for Patients

Adding a comparison number may help patients interpret risk and make better decisions.

Conexiant

March 02, 2026

GLP-1–Progestin and Endometrial Cancer Risk

Adjunct therapy tied to fewer cancers and hysterectomies.

Conexiant

February 27, 2026

Sequencing Therapies in Non-Hodgkin Lymphomas

Guiding oncology practitioners on integrating advanced therapies for B-cell non-Hodgkin lymphomas, JADPRO Live 2025 featured critical insights from F. Brianne Buchanan and Tatjana Grgic.

JADPRO